drugset / Trial / NCT00902200
A Study of AR-12286 in Patient With Elevated Intraocular Pressure (IOP)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Double-masked, randomized, multi-center, placebo-controlled parallel-comparison of AR-12286.
Timeline
- Start
- 2009-05
- Primary completion
- 2009-09
- Completion
- 2009-09
Outcome
Met primary endpoint
paper All 3 concentrations of AR-12286 produced statistically and clinically significant reductions in mean IOP PMID 21794845 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VEROSUDIL | Small molecule | 0.05 % | Other |
| Subject | VEROSUDIL | Small molecule | 0.1 % | Other |
| Subject | VEROSUDIL | Small molecule | 0.25 % | Other |